{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:39:47Z","timestamp":1767706787568,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Adult-onset Still\u2019s disease (AOSD)-like syndrome has rarely been reported as a complication of COVID-19 vaccination. This study reports a 31-year-old female patient who presented with fever, myalgia, arthralgia, pleuropericarditis, leukocytosis, and transaminitis following ChAdOx1 vaccination, and met Yamaguchi\u2019s criteria. A PubMed literature search, performed up until March 2022, identified 10 such cases. A total of 11 cases, including the one in this report, developed AOSD-like syndrome after administration of the viral vector (ChAdOx1) vaccine (six patients) and mRNA vaccine (five patients: BNT162b2 in four and mRNA-1273 in one). There were four male and seven female patients, with their median (Q1, Q3) age and the onset of symptoms after vaccination being 36 years (29, 45) and 10 days (6, 13), respectively. Fever (100%), arthralgia\/arthritis (90.9%), skin rashes (81.8%), and sore throat (81.8%) were the main clinical findings. Pericarditis (45.5%), myocarditis\/cardiac dysfunction (36.4%), pleuritis (54.6%), and pulmonary infiltrations (36.4%) were also common. One patient developed macrophage activation syndrome. One patient responded well to non-steroidal anti-inflammatory drugs, and the other six showed a good response to high-dose corticosteroids alone. Of the remaining four patients, who showed partial responses to high dose corticosteroids, showed good responses to biological agents. AOSD-like syndrome following COVID-19 vaccination shared many similar clinical features and treatment outcomes to those of idiopathic AOSD (but with a higher prevalence of cardiopulmonary involvement in the former). Physicians should be aware of this extremely rare complication to achieve early diagnosis and provide proper management.<\/jats:p>","DOI":"10.3390\/vaccines10071022","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T22:50:23Z","timestamp":1656283823000},"page":"1022","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adult-Onset Still\u2019s Disease-like Syndrome following COVID-19 Vaccination: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-3706","authenticated-orcid":false,"given":"Poramed","family":"Winichakoon","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6097-6064","authenticated-orcid":false,"given":"Wanitcha","family":"Chanloung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerapat","family":"Nantsupawat","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-6122","authenticated-orcid":false,"given":"Worawit","family":"Louthrenoo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Maranini, B., Ciancio, G., and Govoni, M. (2021). Adult-Onset Still\u2019s Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413320"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mitrovic, S., and Fautrel, B. (2021). Clinical Phenotypes of Adult-Onset Still\u2019s Disease: New Insights from Pathophysiology and Literature Findings. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122633"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., Haddad, A., Elias, M., Zisman, D., and Naffaa, M.E. (2021). Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects following mRNA\/DNA SARS-CoV-2 Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9050435"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-onset Still\u2019s disease following COVID-19 vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","article-title":"Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine","volume":"3","author":"Magliulo","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108878","DOI":"10.1016\/j.clim.2021.108878","article-title":"Adult-onset Still\u2019s disease following mRNA COVID-19 vaccination","volume":"233","author":"Sharabi","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.3346\/jkms.2021.36.e344","article-title":"Adult-onset Still\u2019s Disease after BNT162b2 mRNA COVID-19 Vaccine","volume":"36","author":"Park","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_11","first-page":"e21279","article-title":"Adult-Onset Still\u2019s Disease after the ChAdOx1 nCoV-19 Vaccine","volume":"14","author":"AlQudari","year":"2022","journal-title":"Cureus"},{"key":"ref_12","first-page":"3","article-title":"Hyper-inflammation after COVID-19 mARN vaccination: At the crossroads of multisystem inflammatory disease and adult-onset Still\u2019s disease. Does terminology matter?","volume":"60","author":"Baicus","year":"2022","journal-title":"Rom. J. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-022-06065-7","article-title":"New-onset Adult-onset Still\u2019s disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature","volume":"41","author":"Padiyar","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_14","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still\u2019s disease: Data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still\u2019s disease: An Italian multicentre retrospective observational study of manifestations and treatments in 245 patients","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_17","first-page":"52","article-title":"Clinical features and current treatments of adult-onset Still\u2019s disease: A multicentre survey of 517 patients in China","volume":"37","author":"Hu","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_18","first-page":"11","article-title":"Calcineurin inhibitors for adult-onset Still\u2019s disease: A multicentre retrospective cohort study","volume":"38","author":"Nakamura","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13075-021-02688-4","article-title":"Clinical phenotypes and prognostic factors of adult-onset Still\u2019s disease: Data from a large inpatient cohort","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-021-02708-3","article-title":"Latent class analysis of 216 patients with adult-onset Still\u2019s disease","volume":"24","author":"Sugiyama","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/1744666X.2018.1533403","article-title":"Pathogenesis of adult onset still\u2019s disease: Current understanding and new insights","volume":"14","author":"Ruscitti","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral Myocarditis-Incidence, Diagnosis and Management","volume":"34","author":"Olejniczak","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Manfredi, R., Bianco, F., Bucciarelli, V., Ciliberti, G., Guerra, F., Schicchi, N., Tavio, M., Berton, E., Surace, F.C., and Colaneri, M. (2022). Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis following mRNA COVID-19 Vaccination: A Case Series. Vaccines, 10.","DOI":"10.3390\/vaccines10020169"},{"key":"ref_25","unstructured":"European Medicines Agency (2022, June 03). Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2008.01167.x","article-title":"Molecular mechanisms of HLA association with autoimmune diseases","volume":"73","year":"2009","journal-title":"Tissue Antigens"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","article-title":"The MHC locus and genetic susceptibility to autoimmune and infectious diseases","volume":"18","author":"Matzaraki","year":"2017","journal-title":"Genome Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: The role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","article-title":"SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis","volume":"41","author":"Velikova","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e68563","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"eLife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: A prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gracia-Ramos, A.E., Martin-Nares, E., and Hernandez-Molina, G. (2021). New Onset of Autoimmune Diseases following COVID-19 Diagnosis. Cells, 10.","DOI":"10.3390\/cells10123592"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102883","DOI":"10.1016\/j.autrev.2021.102883","article-title":"Rheumatological complications of Covid 19","volume":"20","author":"Zacharias","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/RHU.0000000000001531","article-title":"A Case of Systemic Lupus Erythematosus Flare Triggered by Severe Coronavirus Disease 2019","volume":"26","author":"Raghavan","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2665-9913(20)30396-9","article-title":"First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection","volume":"3","author":"Perrot","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e154886","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155873","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Cyprian, F.S., Nasrallah, G.K., Al Thani, A.A., Almishal, R.O., and Yassine, H.M. (2019). Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses, 11.","DOI":"10.3390\/v11080762"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10067-022-06124-z","article-title":"Two flares of Still\u2019s disease after two doses of the ChAdOx1 vaccine","volume":"41","author":"Roongta","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00296-021-05052-6","article-title":"A flare of Still\u2019s disease following COVID-19 vaccination in a 34-year-old patient","volume":"42","author":"Jeon","year":"2022","journal-title":"Rheumatol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Muench, F., Krusche, M., Sander, L.E., Rose, T., Burmester, G.R., and Schneider, U. (2021). Macrophage activation syndrome in a patient with adult-onset Still\u2019s disease following first COVID-19 vaccination with BNT162b2. BMC Rheumatol., 5.","DOI":"10.1186\/s41927-021-00237-9"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-021-02674-w","article-title":"Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine","volume":"24","author":"Spinelli","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lee, A., Wong, S.Y., and Tay, S.H. (2022). Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety. Vaccines, 10.","DOI":"10.3390\/vaccines10050668"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/7\/1022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:38:44Z","timestamp":1760139524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/7\/1022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["vaccines10071022"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10071022","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2022,6,26]]}}}